Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer.
Clinton TN, Chen Z, Wise H, Lenis AT, Chavan S, Donoghue MTA, Almassi N, Chu CE, Dason S, Rao P, Rodrigues JA, Vasani NB, Ridouani F, Rosenberg JE, Bajorin DF, Teo MY, Bochner BH, Berger MF, Ostrovnaya I, Pietzak EJ, Iyer G, Gao SP, Hu W, Al-Ahmadie HA, Solit DB. Clinton TN, et al. Among authors: almassi n. Cell Rep. 2022 Dec 20;41(12):111859. doi: 10.1016/j.celrep.2022.111859. Cell Rep. 2022. PMID: 36543146 Free PMC article.
Editorial: Radical cystectomy in bladder cancer patients.
Koshkin VS, Almassi N, Aragon-Ching JB. Koshkin VS, et al. Among authors: almassi n. Front Oncol. 2022 Dec 19;12:1113112. doi: 10.3389/fonc.2022.1113112. eCollection 2022. Front Oncol. 2022. PMID: 36601472 Free PMC article. No abstract available.
Editorial Comment.
Almassi N. Almassi N. Urology. 2016 Aug;94:82-3. doi: 10.1016/j.urology.2016.03.054. Epub 2016 Jun 14. Urology. 2016. PMID: 27317469 No abstract available.
Editorial Comment.
Almassi N, Goldman HB. Almassi N, et al. Urology. 2017 Apr;102:98-99. doi: 10.1016/j.urology.2016.10.053. Epub 2017 Jan 11. Urology. 2017. PMID: 28088434 No abstract available.
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance.
Nyame YA, Almassi N, Haywood SC, Greene DJ, Ganesan V, Dai C, Zabell J, Reichard C, Arora H, Zampini A, Crane A, Hettel D, Elshafei A, Fareed K, Stein RJ, Berglund RK, Gong M, Jones JS, Klein EA, Stephenson AJ. Nyame YA, et al. Among authors: almassi n. J Urol. 2017 Sep;198(3):591-599. doi: 10.1016/j.juro.2017.03.123. Epub 2017 Mar 24. J Urol. 2017. PMID: 28347770
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance.
Ganesan V, Dai C, Nyame YA, Greene DJ, Almassi N, Hettel D, Zabell J, Arora H, Haywood S, Crane A, Reichard C, Zampini A, Elshafei A, Stein RJ, Fareed K, Jones JS, Gong M, Stephenson AJ, Klein EA, Berglund RK. Ganesan V, et al. Among authors: almassi n. Urology. 2017 Sep;107:184-189. doi: 10.1016/j.urology.2017.06.014. Epub 2017 Jun 15. Urology. 2017. PMID: 28625591
83 results